buy cialis

Archive for the ‘Blisters’ Category

Packaging Clues Needed

Monday, March 19th, 2012

After counterfeit Avastin surfaced in February, the Institute for Safe Medication Practices (ISMP) reminded nurses, pharmacists, and doctors to remain vigilant when procuring and dispensing medications. Packaging and labeling play key roles in that vigilance. But do you give these professionals enough clues to go by? In its March 8 newsletter, ...

Pfizer Explains Birth Control Pill Recall on YouTube

Wednesday, February 1st, 2012

Pfizer took to the Internet today to address its voluntary recall of approximately one million packs of birth control pills. Recalled are 28 lots of Lo/Ovral-28 (norgestrel and ethinyl estradiol) and Norgestrel and Ethinyl Estradiol Tablets (generic) birth control pills in the United States. Pfizer's Chief Medical Officer Freda Lewis-Hall explained ...

Upping the Bar for Packaging: Up and Away

Friday, December 16th, 2011

I was intrigued to see packaging mentioned in the new child safety program promoted by the Centers for Disease Control and Prevention (CDC) and other partners, Up and Away. The program is part of the PROTECT Initiative, with drug manufacturers, packaging suppliers, and ...

Consider the Point of Consumption

Wednesday, October 26th, 2011

We often talk about making packaging more interesting at the point of sale (POS) to drive patient/consumer interest, but I just heard a better point for you to consider: the "Point of Consumption (POC)." Michael Nieuwesteeg, managing director of the Netherlands Packaging Centre (NVC), who joined me to co-moderate the ...

Study Points To Value Of Calendar Packaging

Friday, June 24th, 2011

A study of patient refill behavior to be published this month in Clinical Therapeutics shows modest--but significant--adherence improvements in patients using calendar blister packaging (CBP). A Pharmacoepidemiologic Analysis of the Impact of Calendar Packaging On Adherence to Self-Administered Medications for Long-Term Use reports on an analysis of pharmacy claims data from ...

Medicaid Compliance Study Shows Value of Packaging, Intervention

Monday, April 25th, 2011

A new study of patients in a community-based Medicaid program shows the benefit of a collaborative approach--one that involves packaging and personal outreach--for improving patients' persistence with their medications. Reported in last month's The American Journal of Geriatric Pharmacotherapy, the study evaluates the impact of Medicine-On-Time's medication management system on nursing ...

New Solutions Debut At Pharmapack

Tuesday, March 22nd, 2011

As presenters at Pharmapack 2011 offered their perspectives on the larger trends driving package design, companies and exhibitors announced packaging innovations and improved delivery systems. Attendees at the Paris venue learned of new bottle designs developed with consumer panels, intelligent blister packaging that underpins trials in telemedicine, and next generation nasal, ...

Still No Discussion of Packaging

Thursday, October 21st, 2010

Today I came across two different stories on the emerging roles that pharmacists are playing in medication therapy management. We received a press release from the National Association of Chain Drug Stores (NACDS) on its participation in the U.S. Senate Health Fair last week in Washington, DC, and later on ...

FDA: “We are not opposed to patient unit-dose packaging”

Tuesday, March 9th, 2010

A while ago we shared a letter from the Healthcare Compliance Packaging Council to FDA regarding an FDA decision out of the Office of Drug Safety “that prohibits generic drug manufacturers from 'calendarizing' unit dose blister cards, strips, and other packaging formats.” We hadn't heard anything official from FDA, so I ...

HCPC Urges FDA to Reconsider Ban on Calendarized Generics that Differ from Branded Drugs

Thursday, October 15th, 2009

The Healthcare Compliance Packaging Council sent the following letter to FDA, HHS, and the White House today. Executive director Peter Mayberry wrote to protest an FDA decision that "prohibits generic drug manufacturers from calendarizing unit dose blister cards, strips, and other packaging formats" if the branded drug was not packaged ...